Login to Your Account



Fighting Hypometabolism

Accera Feeds the Brain to Fight Alzheimer's Disease

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, December 3, 2012

While most of the industry focuses on beta amyloid and tau as targets for Alzheimer's disease, Accera Inc. has turned its attention to a deficit in the ability of Alzheimer's patients' brain cells to metabolize glucose.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription